"Desoximetasone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A topical anti-inflammatory glucocorticoid used in DERMATOSES, skin allergies, PSORIASIS, etc.
| Descriptor ID |
D003899
|
| MeSH Number(s) |
D04.210.500.745.432.719.260 D04.210.500.908.238.250
|
| Concept/Terms |
Desoximetasone- Desoximetasone
- Desoxymethasone
- 17-Desoxymethasone
- 17 Desoxymethasone
- Deoxydexamethasone
|
Below are MeSH descriptors whose meaning is more general than "Desoximetasone".
Below are MeSH descriptors whose meaning is more specific than "Desoximetasone".
This graph shows the total number of publications written about "Desoximetasone" by people in this website by year, and whether "Desoximetasone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 6 | 0 | 6 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Desoximetasone" by people in Profiles.
-
Is topical treatment effective for psoriasis in patients who failed topical treatment? J Dermatolog Treat. 2021 Feb; 32(1):41-44.
-
Psoriasis and Atopic Dermatitis "Resistant" to Topical Treatment Responds Rapidly to Topical Desoximetasone Spray. J Cutan Med Surg. 2019 Mar/Apr; 23(2):157-163.
-
Six week evaluation of the potential for topical desoximetasone 0.25% spray to induce photoallergic skin reaction. J Dermatolog Treat. 2018 May; 29(3):269-271.
-
4-Day evaluation of the irritation potential of topical desoximetasone 0.25% and 0.05% spray on light-exposed skin. J Dermatolog Treat. 2018 Jun; 29(4):415-417.
-
A Randomized, Double-Blind, Placebo-Controlled Study of the Vasoconstrictor Potency of Topical 0.25% Desoximetasone Spray: A High to Super High Range of Potency (Class I to Class II) Corticosteroid Formulation. J Drugs Dermatol. 2017 Oct 01; 16(10):972-975.
-
Topical Desoximetasone 0.25% Spray and Its Vehicle Have Little Potential for Irritation or Sensitization. J Drugs Dermatol. 2017 Aug 01; 16(8):755-758.
-
Desoximetasone 0.25% spray, adrenal suppression and efficacy in extensive plaque psoriasis. J Dermatolog Treat. 2018 Feb; 29(1):36-38.
-
Topical 0.25% desoximetasone spray efficacy for moderate to severe plaque psoriasis: a randomized clinical trial. J Dermatolog Treat. 2018 Feb; 29(1):32-35.